Crsf Cancer Research And Statistic Foundation

8:28

SESSION 5: Upfront Cytoreductive Nephrectomy in Metastatic RCC | 05th Knowledge Series
CRSF - Cancer Research and Statistic Foundation
33 views
3:09

Dr. Rakesh Pinninti -MA02.05 A Phase I Study of Afatinib in Combination With Osimertinib in Patients
CRSF - Cancer Research and Statistic Foundation
96 views
13:20

CRSF 7th Masterclass | Second-Line Treatment Selection for ED SCLC by Dr. Akansha Choudhary
CRSF - Cancer Research and Statistic Foundation
42 views
13:54

CRSF 7th Masterclass | Resistance to ROS1 Therapy & Post-Resistance Strategies by Dr. Abhishek Anand
CRSF - Cancer Research and Statistic Foundation
74 views
7:01

Dr Kumar Prabhash | Expert Comment
CRSF - Cancer Research and Statistic Foundation
65 views
11:36

CRSF 7th Masterclass in Lung Cancer | Regimen Selection for Poor PS & SVCO by Dr. Tarachand Gupta
CRSF - Cancer Research and Statistic Foundation
54 views
1:07

Expert Comment
CRSF - Cancer Research and Statistic Foundation
11 views
26:17

Panel Discussion | Dr Krishna Prasad | Molecular testing in Lung cancer The best Methodology
CRSF - Cancer Research and Statistic Foundation
40 views
1:17

CRSF 2024: Exciting Session | Knowledge Series for Genitourinary Cancers Day 1 with Dr. Ashwin
CRSF - Cancer Research and Statistic Foundation
15 views
1:18

Dr Vivek Belathur | Welcome & Introduction
CRSF - Cancer Research and Statistic Foundation
14 views
8:38

Dr Minit Shah | Sugemalimab vs Placebo after cCRT or sCRT in Patients with Unresectable stage III
CRSF - Cancer Research and Statistic Foundation
70 views
9:23

Dr Vivek | Randomized open-label phase III KEYLYNK-010 study
CRSF - Cancer Research and Statistic Foundation
15 views
7:48

CRSF 2024: Exciting Session | Knowledge Series for Genitourinary Cancers Day 1 with Dr. Mondal
CRSF - Cancer Research and Statistic Foundation
12 views
15:34

Optimizing Neoadjuvant Immunotherapy in NSCLC by Dr. Kaushik | Oncology Perspective 2024
CRSF - Cancer Research and Statistic Foundation
46 views
1:55

Dr Jyoti Arora | Welcome & Introduction
CRSF - Cancer Research and Statistic Foundation
58 views
28:19

Panel Discussion Dr Vamshi Krihsna |Sequencing agents for HR+VE MBC in clinical Practice Perspective
CRSF - Cancer Research and Statistic Foundation
12 views
7:12

Dr Smriti Hari | A Multicentre prospective study to predict pathologic
CRSF - Cancer Research and Statistic Foundation
39 views
2:14

Closing Remarks by Dr. Nandini Menon: Reflections and Future Directions | CRSF 2024
CRSF - Cancer Research and Statistic Foundation
38 views
9:02

CRSF 7th Masterclass | First-Line RET Targeted Therapy in Lung Cancer by Dr. Chakor Vora
CRSF - Cancer Research and Statistic Foundation
63 views
Today Top Searches
Categories
Recently Searched Keywords